New York – November 20, 2020 – Cooley advised Pharmapacks on its more than $250 million strategic investment from The Carlyle Group. The growth investment values the ecommerce enablement platform and retail seller at approximately $1.1 billion. Cooley lawyers Sacha Ross, David Silverman and Ariel Rom led the team advising Pharmapacks on the investment.
“Pharmapacks is experiencing unprecedented growth with massive market support and highly attractive industry dynamics,” Andrew Vagenas, chief executive officer of Pharmapacks, said in a news release. “We are thrilled that our partnership with Carlyle, a world-class investment firm with extensive connectivity, data and global resources, will provide us with an opportunity to take significant steps to enter the next phase of our growth plans.”
Pharmapacks was founded as a single brick-and-mortar pharmacy and has evolved into a platform that empowers brands with a complete and cost-effective logistics, fulfillment, marketing and sales solution. Since 2010, Pharmapacks has cultivated extensive partnerships with consumer brands across ecommerce marketplaces in North America. The company is trusted by millions of customers to provide for their daily needs. After reaching more than $250 million in sales in 2019, Pharmapacks is on track to achieve approximately 60% year-over-year growth.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 1,100+ lawyers across 16 offices in the United States, Asia and Europe.